Related Experiment Video
Updated: Jul 16, 2026

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
Published on: July 6, 2016
Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms
D Schober1, P Kronenberger, E Prchla
1Department of General and Experimental Pathology, University of Vienna, Austria.
Abstract:
Intercellular adhesion molecule 1 and the low-density lipoprotein receptor are used for cell entry by major and minor receptor group human rhinoviruses (HRVs), respectively. Whereas minor-group viruses, exemplified by HRV2, transfer their genomic RNA to the cytoplasm through a pore in the endosomal membrane (E. Prchla, C. Plank, E. Wagner, D. Blaas, and R. Fuchs, J. Cell Biol. 131:111-123, 1995), the mechanism of in vivo uncoating of major-group HRVs has not been elucidated so far. Using free-flow electrophoresis, we performed a comparative analysis of cell entry by HRV2 and the major group rhinovirus HRV14. Here we demonstrate that this technique allows the separation of free viral particles from those associated with early endosomes, late endosomes, and plasma membranes. Upon free-flow electrophoretic separation of microsomes, HRV14 was recovered from endosomes under conditions which prevent uncoating, whereas the proportion of free viral particles increased with time under conditions which promote uncoating. The remaining virus eluted within numerous fractions corresponding to membraneous material, with no clear endosomal peaks being discernible. This suggests that uncoating of HRV14 results in lysis of the endosomal membrane and release of subviral 135S and 80S particles into the cytoplasm.
Insights
Major and minor group rhinoviruses (HRVs) use different cell entry mechanisms. HRV14 uncoating involves endosomal membrane lysis, releasing viral RNA into the cytoplasm.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Human rhinoviruses (HRVs) utilize specific receptors for cell entry: intercellular adhesion molecule 1 for major group HRVs and the low-density lipoprotein receptor for minor group HRVs.
- While the cytoplasmic RNA transfer mechanism is known for minor group HRV2, the in vivo uncoating process for major group HRVs remains unclear.
Purpose of the Study:
- To comparatively analyze the cell entry mechanisms of HRV2 (minor group) and HRV14 (major group).
- To elucidate the in vivo uncoating mechanism of major group HRVs.
Main Methods:
- Comparative analysis of HRV2 and HRV14 cell entry using free-flow electrophoresis.
- Separation of viral particles from endosomal and plasma membrane fractions.
- Assessment of viral uncoating under varying conditions.
Main Results:
- Free-flow electrophoresis effectively separated free viral particles from those associated with endosomes and plasma membranes.
- HRV14 was primarily recovered from endosomes under conditions that inhibit uncoating.
- Under uncoating-promoting conditions, the proportion of free HRV14 particles increased, with viral elution correlating with membraneous material rather than distinct endosomal peaks.
Conclusions:
- The uncoating of HRV14 appears to involve the lysis of the endosomal membrane.
- This lysis leads to the release of subviral 135S and 80S particles into the cytoplasm.
- The findings provide insight into the distinct cell entry pathways of major group HRVs.
More Related Videos
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-Mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Influenza
Respiratory Syncytial Virus Disease
Inhibitors Of Virion Release